INTS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Intensity Therapeutics Inc (INTS) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of positive financial performance, absence of significant trading trends, and no recent news or catalysts make this stock a hold rather than a buy. The technical indicators are neutral, and there are no strong proprietary trading signals to support an immediate purchase.
The MACD is slightly positive at 0.00159, indicating mild bullish momentum, but the RSI at 49.859 is neutral. Moving averages are converging, showing no clear trend. The stock is trading near its pivot point of 0.364, with resistance at 0.384 and support at 0.343. Overall, technical indicators suggest a neutral trend with no strong buy signal.
NULL identified. No recent news or significant trading trends. Technical indicators are neutral.
There are no recent trading trends from insiders or hedge funds, and no recent news or events to act as positive catalysts.
In Q3 2025, the company reported zero revenue growth (0.00% YoY) and a net income loss of -$2,671,000 (-23.97% YoY). EPS dropped significantly to -0.06 (-76.00% YoY). Gross margin remained at 0, showing no improvement. Overall, the financial performance is weak.
No analyst rating or price target data available. The lack of valuation data and Wall Street sentiment makes it difficult to gauge professional opinions on the stock.
